Dramatic advances in human health beckon if pharma can help build ‘the Digitome’, a vast data commons
RWE shows great promise in helping accelerate treatments for rare disease
A new decade is here. And despite the incredible science, pharma is ill-equipped.
There is a new surge of interest in telemedicine’s potential to optimize clinical trials, but is this what patients want?